Chongqing Pharscin Pharmaceutical Co Ltd (002907) — Cash Flow-to-Debt Ratio
Chongqing Pharscin Pharmaceutical Co Ltd (002907) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥833.94K could theoretically repay 0% of its total liabilities (CN¥287.66 Million) in one year. See Chongqing Pharscin Pharmaceutical Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Chongqing Pharscin Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Chongqing Pharscin Pharmaceutical Co Ltd across 12 annual periods. For the full cash flow conversion analysis, see 002907 operating cash flow.
Annual Cash Flow-to-Debt Ratio for Chongqing Pharscin Pharmaceutical Co Ltd (2013–2024)
Year-by-year debt coverage analysis for Chongqing Pharscin Pharmaceutical Co Ltd. Check Chongqing Pharscin Pharmaceutical Co Ltd (002907) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.63x | CN¥161.77 Million | CN¥257.55 Million | ▼ -33.1% |
| 2023 | 0.94x | CN¥219.34 Million | CN¥233.53 Million | ▲ +1745.2% |
| 2022 | 0.05x | CN¥13.04 Million | CN¥256.28 Million | ▼ -68.9% |
| 2021 | 0.16x | CN¥82.85 Million | CN¥505.56 Million | ▼ -22.2% |
| 2020 | 0.21x | CN¥113.64 Million | CN¥539.59 Million | ▲ +81.0% |
| 2019 | 0.12x | CN¥65.92 Million | CN¥566.67 Million | ▼ -3.2% |
| 2018 | 0.12x | CN¥31.80 Million | CN¥264.72 Million | ▼ -75.6% |
| 2017 | 0.49x | CN¥81.34 Million | CN¥165.20 Million | ▲ +62.8% |
| 2016 | 0.30x | CN¥57.73 Million | CN¥190.91 Million | ▼ -20.6% |
| 2015 | 0.38x | CN¥66.10 Million | CN¥173.59 Million | ▲ +347.5% |
| 2014 | 0.09x | CN¥20.22 Million | CN¥237.62 Million | ▼ -68.7% |
| 2013 | 0.27x | CN¥47.34 Million | CN¥174.39 Million | — |